-+ 0.00%
-+ 0.00%
-+ 0.00%

MATA - DURAVYU MENCAPAI PENGURANGAN BEBAN RAWATAN 42% BERBANDING AFLIBERCEPT

Reuters·08/17/2026 11:02:20